Nrx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Bioequivalence Determination By Office Of Generic Drugs For Nrx's Preservative-Free Ketamine Application March 18, 2026 depression ONLY AVAILABLE IN PAID PLANS. Originally reported by menafn. Read more Source: https://menafn.com/1110871812/Nrx-Pharmaceuticals-NasdaqNRXP-Announces-FDA-Bioequivalence-Determination-By-Office-Of-Generic-Drugs-For-Nrxs-Preservative-Free-Ketamine-Application
